AI is transforming how biopharma generates evidence, from extracting insights from complex clinical data to scaling analyses that were previously too resource-intensive to pursue. But as AI expands what’s possible, high-quality, validated data becomes even more critical. In this panel, experts from across the industry will discuss how trusted data and scientific rigor are enabling responsible AI adoption and accelerating oncology research.